IL6 and plasma cell myeloma: Following the initial observation that EZH2 is over expressed in aggressive myelomas [23, 24], we demonstrated that EZH2 expression is driven by IL-6 and is required for the proliferation of growth-factor-independent human myeloma cell lines (HMCLs) harboring a ras mutation [25].